Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 2
2015 pubmed 27 citations

Eotaxin-3 (CCL26) exerts innate host defense activities that are modulated by mast cell proteases.

Gela. A A; Kasetty. G G; Jovic. S S; Ekoff. M M; Nilsson. G G; Mörgelin. M M; Kjellström. S S; Pease. J E JE; Schmidtchen. A A; Egesten. A A

Key Findings

  • Full‑length CCL26 kills several airway pathogens (Strep pneumoniae, Staph aureus, H. influenzae, Pseudomonas) by disrupting bacterial membranes.
  • The C‑terminal (tail) part of CCL26 retains strong antibacterial activity even in salty (physiological) conditions.
  • Proteolysis by mast cell enzymes creates an N‑terminal fragment that neutralizes lipopolysaccharide (LPS) but does not activate the CCR3 receptor.

Practical Outcomes

  • For biohackers, the work suggests that boosting or mimicking eotaxin‑3 activity could be a novel way to support airway immunity, especially during allergic inflammation. However, the research does not provide dosage, delivery method, or safety data, so it remains a mechanistic insight rather than a ready‑to‑use protocol.

Summary

The study shows that the immune signaling protein eotaxin‑3 (CCL26), which is usually linked to allergic reactions, can also kill common airway bacteria by breaking their membranes. When mast cell enzymes cut CCL26, the pieces keep some of the antibacterial power or can neutralize bacterial toxins, but they no longer trigger the usual receptor signals.

Abstract

During bacterial infections of the airways, a Th1-profiled inflammation promotes the production of several host defense proteins and peptides with antibacterial activities including β-defensins, ELR-negative CXC chemokines, and the cathelicidin LL-37. These are downregulated by Th2 cytokines of the allergic response. Instead, the eosinophil-recruiting chemokines eotaxin-1/CCL11, eotaxin-2/CCL24, and eotaxin-3/CCL26 are expressed. This study set out to investigate whether these chemokines could serve as innate host defense molecules during allergic inflammation. Antibacterial activities of the eotaxins were investigated using viable count assays, electron microscopy, and methods assessing bacterial permeabilization. Fragments generated by mast cell proteases were characterized, and their potential antibacterial, receptor-activating, and lipopolysaccharide-neutralizing activities were investigated. CCL11, CCL24, and CCL26 all showed potent bactericidal activity, mediated through membrane disruption, against the airway pathogens Streptococcus pneumoniae, Staphylococcus aureus, Nontypeable Haemophilus influenzae, and Pseudomonas aeruginosa. CCL26 retained bactericidal activity in the presence of salt at physiologic concentrations, and the region holding the highest bactericidal activity was the cationic and amphipathic COOH-terminus. Proteolysis of CCL26 by chymase and tryptase, respectively, released distinct fragments of the COOH- and NH2 -terminal regions. The COOH-terminal fragment retained antibacterial activity while the NH2 -terminal had potent LPS-neutralizing properties in the order of CCL26 full-length protein. An identical fragment to NH2 -terminal fragment generated by tryptase was obtained after incubation with supernatants from activated mast cells. None of the fragments activated the CCR3-receptor. Taken together, the findings show that the eotaxins can contribute to host defense against common airway pathogens and that their activities are modulated by mast cell proteases.

Study Information

Provider

pubmed

Year

2015

Date

2015-02-01T00:00:00.000Z

DOI

10.1111/all.12542

Citations

27

References

35